Literature DB >> 31387002

Magnesium lithospermate B attenuates renal injury in 5/6 renal ablation/infarction rats by mitochondrial pathway of apoptosis.

Meng Wang1, Liuyi Yang2, Jing Yang3, Yuan Zhou4, Chen Wang5.   

Abstract

Apoptosis is closely interconnected with the severity of renal injury. Magnesium lithospermate B (MLB) extracted from Salviae miltiorrhizae radix showed a wide range of renoprotective effects. However, the underlying mechanisms under beneficial effects have not been elucidated. This study was conducted to investigate whether MLB could mediate renal protection and attenuate apoptosis by mitochondrial pathway. In the present study, the rat model of chronic renal failure (CRF) was established by the 5/6 renal ablation/infarction (A/I) operation. 28 days after the surgery, 30 rats were randomly divided into three groups: sham group, 5/6 (A/I) group and 5/6 (A/I) + MLB group. After 56 days of treatment, we detected the severity of kidney injury, the degree of mitochondrial bax oligomerization and cytochrome c release along with the expression of P53 protein. Our results showed that MLB markedly attenuated kidney injury and apoptosis in 5/6 (A/I) model rats with CRF. MLB effectively inhibited mitochondrial bax accumulation and release of cytochrome c into the cytosol and down-regulated the levels of p53 phosphorylation and acetylation. These data showed that MLB could contribute to renal protection by inhibiting mitochondrial pathway of apoptosis.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Apoptosis; Chronic kidney disease; Magnesium lithospermate B; Mitochondria

Mesh:

Substances:

Year:  2019        PMID: 31387002     DOI: 10.1016/j.biopha.2019.109316

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

Review 1.  Magnesium in renal fibrosis.

Authors:  Mengtuan Long; Xiaoyu Zhu; Xuejiao Wei; Dan Zhao; Lili Jiang; Chenhao Li; Die Jin; Changxiu Miao; Yujun Du
Journal:  Int Urol Nephrol       Date:  2022-01-20       Impact factor: 2.266

Review 2.  Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease.

Authors:  Mingming Zhao; Yi Yu; Rumeng Wang; Meiying Chang; Sijia Ma; Hua Qu; Yu Zhang
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

Review 3.  Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension.

Authors:  Zhifeng Xue; Yixuan Li; Mengen Zhou; Zhidong Liu; Guanwei Fan; Xiaoying Wang; Yan Zhu; Jian Yang
Journal:  Front Pharmacol       Date:  2021-11-09       Impact factor: 5.810

4.  Effect of Fushengong Decoction on PTEN/PI3K/AKT/NF-κB Pathway in Rats With Chronic Renal Failure via Dual-Dimension Network Pharmacology Strategy.

Authors:  Hongyu Luo; Munan Wang; Ke Xu; Qiyao Peng; Bo Zou; Shi Yin; Chao Yu; Lingyan Ren; Ping Li; Li Tang; Yongbo Peng; Xuekuan Huang
Journal:  Front Pharmacol       Date:  2022-03-15       Impact factor: 5.810

Review 5.  Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms.

Authors:  Yunlai Wang; Ye Feng; Manman Li; Mo Yang; Gaoxiang Shi; Zihua Xuan; Dengke Yin; Fan Xu
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

6.  Magnesium Lithospermate B Protects Against Cisplatin-Induced Acute Kidney Injury via Alleviating Mitochondrial Dysfunction.

Authors:  Daoqi Shen; Man Guo; Xuemei Geng; Jinbo Yu; Zhen Zhang; Jing Lin; Pan Lin; Xiaoqiang Ding; Xialian Xu
Journal:  Drug Des Devel Ther       Date:  2022-07-15       Impact factor: 4.319

7.  Shen Shuai II Recipe Attenuates Apoptosis in 5/6 Renal Ablation/Infarction Rats by Inhibiting p53 and the Mitochondrial Pathway of Apoptosis.

Authors:  Meng Wang; Jing Yang; Chen Wang
Journal:  Oxid Med Cell Longev       Date:  2020-02-07       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.